stockrow
Friday 6 November 2026
Export SMMT’s income statement to Excel — free account
Summit Therapeutics PLC
SMMT Healthcare Biotechnology
Summit Therapeutics PLC’s revenue for fiscal 2022 (year ended December 2022) was $705,000.00.
- EPS
- +63.2%
- Free cash flow
- −112.8%
Quarter to June 2026, against a year earlier
16.18
1.99
+14.02%
Follow SMMT
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Jan '19 | Dec '18 | Jan '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
713.76 | 412.67 | 186.24 | 648.61 | 71.79 | 66.42 | 63.84 | 35.63 | 28.59 | 26.16 |
Receivables |
6.54 | 11.08 | 3.47 | 7.62 | 24.32 | 19.73 | 14.39 | 26.37 | 13.21 | 20.55 |
Other current assets |
— | — | — | 0.49 | 1.20 | 1.52 | 1.40 | — | 9.24 | — |
Total current assets |
720.30 | 423.75 | 189.71 | 656.71 | 97.31 | 87.67 | 79.63 | 62.00 | 51.04 | 46.71 |
Property, Plant, Equpment (Net) |
1.06 | 0.25 | 0.20 | 0.91 | 0.69 | 0.73 | 0.52 | 0.82 | 1.15 | 1.05 |
Long-term receivables |
— | 0.70 | 0.96 | — | — | — | — | — | — | — |
Goodwill and Intangible Assets (Total) |
2.00 | 1.86 | 1.89 | 1.80 | 12.41 | 13.55 | 15.08 | 16.48 | 24.55 | 22.47 |
Long-term assets (Other) |
7.21 | 2.55 | 4.32 | 0.58 | 0.17 | — | — | — | — | — |
Total non-current assets |
30.88 | 11.81 | 13.24 | 7.46 | 16.06 | 14.82 | 16.62 | 17.29 | — | 23.52 |
Total Assets |
751.18 | 435.56 | 202.95 | 664.17 | 113.37 | 102.50 | 96.25 | 79.29 | 76.74 | 70.23 |
Accounts Payable |
20.29 | 4.64 | 2.67 | 0.36 | 4.37 | 6.14 | 4.47 | 11.76 | 6.28 | 11.62 |
Accrued Expenses |
47.03 | 31.53 | 14.21 | 16.31 | 11.32 | 3.28 | 5.74 | — | — | — |
Current Revenue (Deferred) |
— | — | — | — | 7.94 | 8.37 | 2.62 | 4.48 | — | 13.03 |
Other current liabilities |
2.28 | 1.80 | 0.72 | 20.43 | 0.90 | 1.71 | 0.47 | 0.83 | 26.10 | — |
Total current liabilities |
72.99 | 41.73 | 20.41 | 38.78 | 25.62 | 19.89 | 13.77 | 17.07 | 32.37 | 24.65 |
Long Term Debt (Total) |
— | — | 100.00 | 494.54 | — | 0.08 | 0.42 | — | — | — |
Non-current Revenue (Deferred) |
— | — | — | — | — | 0.57 | 0.49 | 1.10 | 38.78 | 23.47 |
Long Term Tax Liability (Deferred) |
— | — | — | — | — | — | — | 2.22 | 3.38 | 3.10 |
Non-current Liabilities (Other) |
1.83 | 1.63 | 1.56 | 1.43 | 2.78 | 2.51 | 2.70 | 2.46 | 6.73 | 6.16 |
Total non-current liabilities |
19.33 | 5.08 | 104.85 | 498.73 | 4.47 | 3.16 | 3.62 | 5.78 | — | 32.72 |
Total liabilities |
92.32 | 46.81 | 125.26 | 537.51 | 30.09 | 23.05 | 17.39 | 22.85 | 81.26 | 57.37 |
Additional Paid In Capital |
2,947.81 | 1,598.23 | 1,066.38 | 504.77 | 384.05 | 293.37 | 241.20 | 123.13 | — | 78.39 |
Common Stock (Net) |
7.75 | 7.38 | 7.02 | 2.11 | 0.98 | 0.83 | 0.67 | 2.13 | 1.05 | 0.96 |
Retained Earnings |
(2,294.16) | (1,214.57) | (993.26) | (378.33) | (299.55) | (210.95) | (158.25) | (100.95) | (129.31) | (105.28) |
Shareholders Equity (Other) |
— | — | — | — | — | — | — | 32.14 | — | 38.78 |
Common Equity (Total) |
658.86 | 388.75 | 77.69 | 126.65 | 83.28 | 79.45 | 78.86 | 56.44 | (4.53) | 12.85 |
Shareholders Equity (Total) |
658.86 | 388.75 | 77.69 | 126.65 | 83.28 | 79.45 | 78.86 | 56.44 | (4.53) | 12.85 |
Shareholders Equity and Liabilities (Total) |
751.18 | 435.56 | 202.95 | 664.17 | 113.37 | 102.50 | 96.25 | 79.29 | — | 70.23 |
Shares (Common) |
775.37 | 737.63 | 701.66 | 211.09 | 98.04 | 82.58 | 67.18 | 32.08 | — | 14.71 |
Shareholders Equity (Tangible) |
656.86 | 386.88 | 75.80 | 124.86 | 70.88 | 65.91 | 63.78 | 39.97 | — | (9.61) |
Net Debt |
(713.76) | (412.67) | (86.24) | (154.07) | (71.79) | (66.34) | (63.42) | (35.63) | (28.59) | (26.16) |
Total Debt |
— | — | 100.00 | 494.54 | — | 0.08 | 0.42 | — | — | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Nov 2026